Clinical Trial Update: A Prospective Study to Evaluate the Role of T-Cell Dysfunction in Patients Who Present Symptoms Associated With Long COVID, Lyme Disease and Myalic Encephalomyelitis / Chronic Fatigue Syndrome Using the Vira Immune Fluorospot T Cell Assay

View source ↗

Summary

A prospective study sponsored by ViraxBio Labs is evaluating T-cell dysfunction in patients with Long COVID, post-transplant lymphoproliferative disorder, and M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Myalgic Encephalomyelitis Chronic Fatigue Syndrome
• Post-transplant Lymphoproliferative Disorder

Snippet

Sponsor: ViraxBio Labs | Conditions: Long COVID, PTLDs | Status: ACTIVE_NOT_RECRUITING